Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

NCT04082910 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
Hematological Malignancy

Interventions

DRUG: Metoprolol
DRUG: metoprolol, infliximab, etanercept, tocilizumab and/or other agents

Sponsor

Chinese PLA General Hospital